Bill Miller Miller Value Partners
Bill Miller is a legendary value-oriented investor best known for a long streak of beating the S&P 500 while managing Legg Mason Value Trust, and later for Miller Value Partners. His process has always been flexible, incorporating both traditional value and growth-at-a-reasonable-price ideas when fundamentals support them. Miller remains a closely followed voice for contrarian equity ideas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lumen
LUMN
|
+$47.2M |
| 2 |
FLXN
Flexion Therapeutics, Inc.
FLXN
|
+$36.8M |
| 3 |
Warner Bros
WBD
|
+$33.3M |
| 4 |
SFIX
Stitch Fix
SFIX
|
+$31.8M |
| 5 |
FTRPR
Frontier Communications Corporation 11.125% Series A Mandatory Convertible Preferred Stock
FTRPR
|
+$21M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MGIC Investment
MTG
|
+$33.6M |
| 2 |
RH
RH
|
+$26.3M |
| 3 |
Gilead Sciences
GILD
|
+$26.2M |
| 4 |
American Eagle Outfitters
AEO
|
+$14.8M |
| 5 |
JPM.WS
JPMorgan Chase
JPM.WS
|
+$10.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 26.61% |
| 2 | Healthcare | 20.07% |
| 3 | Financials | 17.05% |
| 4 | Industrials | 11.82% |
| 5 | Communication Services | 9.57% |
Similar funds
Bill Miller's Q4 2017 Portfolio in Review
As of Q4 2017, Bill Miller held 126 positions worth $2.35B, up 1% from $2.33B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Bill Miller's Q4 2017 filing shows 12 new, 24 increased, 42 reduced and 14 closed positions. Its largest new stake was Lumen: 2,786,450 shares worth $46.5M. The largest sale was MGIC Investment, an estimated $33.6M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Bill Miller's largest Q4 2017 buy was Lumen: 2,786,450 shares worth $46.5M.
- Bill Miller added most to Flexion Therapeutics, Inc. in Q4 2017, an estimated $36.8M increase.
- Bill Miller's biggest Q4 2017 reduction was MGIC Investment, cutting an estimated $33.6M.
- Bill Miller fully exited Gilead Sciences in Q4 2017, selling an estimated $26.2M.
- Bill Miller's ten largest holdings make up 42% of its $2.35B portfolio in Q4 2017.
- Bill Miller opened 12 new positions and closed 14 in Q4 2017.
- Bill Miller's portfolio value rose 1% quarter-over-quarter to $2.35B.
Based on Miller Value Partners's 13F filing for Q4 2017, filed 14 Feb 2018.